Microbial Drug Resistance

SJR Rank #9,763H-index: 80SJR: 0.605Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Mary Ann Liebert Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Medicine (miscellaneous)Q2
  • ImmunologyQ3
  • MicrobiologyQ3
  • Microbiology (medical)Q3
  • PharmacologyQ3

Areas: Immunology and Microbiology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Antibiotic Resistance in BacteriaAntimicrobial Resistance in StaphylococcusBacterial biofilms and quorum sensingPharmaceutical and Antibiotic Environmental ImpactsBacterial Identification and Susceptibility TestingAntibiotics Pharmacokinetics and EfficacyPneumonia and Respiratory InfectionsSalmonella and Campylobacter epidemiologyAntibiotic Use and ResistanceVibrio bacteria research studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs070140210280

Documents per Year

2022202503570105140

Detailed Information

ISSN

1076-6294, 1931-8448

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

1.81

References per Document

41.43

Coverage

1995-2026

Scope

Microbial Drug Resistance (MDR) is an international, peer-reviewed journal that covers the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community. The Journal addresses the serious challenges of trying to decipher the molecular mechanisms of drug resistance. MDR provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports. MDR coverage includes: Molecular biology of resistance mechanisms Virulence genes and disease Molecular epidemiology Drug design Infection control.

Metrics from SCImago Journal Rank 2025. View on SCImago